|
|
Gelesis Holdings Inc (GLS) |
|
Overall company Market Share Q2 2023 |
*Market share is calculated based on total revenue.
Publicly Traded Peers of Gelesis Holdings Inc
Aeterna Zentaris Inc
Share Performance
-52.17%
One Year
|
Aeterna Zentaris Inc
Profile
Aeterna Zentaris Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies in oncology, endocrinology, and women's health. Their business model involves researching, acquiring, developing, and licensing potential drug candidates to bring them to market and address unmet medical needs.
More about Aeterna Zentaris Inc 's Market Share
|
Bellerophon Therapeutics inc
Share Performance
0.00%
This Year
|
Bellerophon Therapeutics inc
Profile
Bellerophon Therapeutics Inc operates under a business model focused on developing and commercializing innovative therapies for cardiopulmonary diseases. They aim to leverage their unique technology platform to advance their product pipeline, ultimately improving patient outcomes and driving sustainable growth in the healthcare market.
More about Bellerophon Therapeutics inc's Market Share
|
Cingulate Inc
Share Performance
-25.10%
This Year
|
Cingulate Inc
Profile
Cingulate Inc operates as a software development company, specializing in delivering innovative solutions for various industries. With a focus on cutting-edge technologies, they provide customized software products and services to meet the specific needs of their clients. Their business model revolves around developing and implementing software solutions that optimize processes and enhance efficiency within organizations.
More about Cingulate Inc 's Market Share
|
Ironwood Pharmaceuticals inc
Share Performance
-82.18%
One Year
|
Ironwood Pharmaceuticals inc
Profile
Ironwood Pharmaceuticals Inc is a biotechnology company that focuses on the development and commercialization of medicines for gastrointestinal disorders. Their business model involves discovering, developing, and marketing innovative treatments for conditions like irritable bowel syndrome and chronic constipation. They aim to achieve growth and profitability by leveraging their research capabilities and collaborating with strategic partners in the healthcare industry.
More about Ironwood Pharmaceuticals inc 's Market Share
|
Landos Biopharma Inc
Share Performance
+430.79%
This Year
|
Landos Biopharma Inc
Profile
Lando's Biopharma Inc is a pharmaceutical company that focuses on developing and commercializing innovative biopharmaceutical products to address unmet medical needs. Their business model revolves around conducting research and development, obtaining regulatory approvals, and marketing and selling their products in the global pharmaceutical market.
More about Landos Biopharma Inc 's Market Share
|
Phathom Pharmaceuticals Inc
Share Performance
-14.96%
30 Days
|
Phathom Pharmaceuticals Inc
Profile
Phathom Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing treatments for gastrointestinal diseases. Their business model involves advancing their pipeline of drug candidates through research and development, and seeking regulatory approval for commercialization. By strategically targeting unmet medical needs in the gastrointestinal space, Phathom Pharmaceuticals aims to provide innovative solutions to improve patient outcomes.
More about Phathom Pharmaceuticals Inc 's Market Share
|
Relmada Therapeutics Inc
Share Performance
-2.62%
Over The Past 5 Days
|
Relmada Therapeutics Inc
Profile
Relmada Therapeutics Inc's business model revolves around the development and commercialization of innovative therapies for the treatment of central nervous system (CNS) disorders.
More about Relmada Therapeutics Inc's Market Share
|
Zynerba Pharmaceuticals Inc
Share Performance
+93.57%
One Year
|
Zynerba Pharmaceuticals Inc
Profile
Zynerba Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing innovative transdermal cannabinoid therapies. They utilize their proprietary technology to deliver cannabinoid molecules through the skin, providing targeted treatment for various medical conditions. Zynerba Pharmaceuticals aims to provide effective, safe, and convenient therapeutic options for patients in need.
More about Zynerba Pharmaceuticals Inc 's Market Share
|
Arena Pharmaceuticals Inc
Share Performance
+6.34%
Over The Past 5 Days
|
Arena Pharmaceuticals Inc
Profile
Arena Pharmaceuticals Inc's business model is focused on the discovery and development of innovative therapies for various medical conditions.
More about Arena Pharmaceuticals Inc 's Market Share
|
Diamedica Therapeutics Inc
Share Performance
+100.00%
One Year
|
Diamedica Therapeutics Inc
Profile
Diamedica Therapeutics Inc's business model focuses on developing and commercializing innovative therapies to improve patient outcomes in areas of unmet medical needs.
More about Diamedica Therapeutics Inc 's Market Share
|
Galmed Pharmaceuticals Ltd
Share Performance
-6.82%
Over The Past 5 Days
|
Galmed Pharmaceuticals Ltd
Profile
Galmed Pharmaceuticals Ltd's business model focuses on the development and commercialization of innovative therapeutic solutions, particularly in the field of liver and metabolic diseases.
More about Galmed Pharmaceuticals Ltd 's Market Share
|
Eli Lilly And Company
Share Performance
-8.59%
30 Days
|
Eli Lilly And Company
Profile
Eli Lilly and Company operates as a global pharmaceutical firm that focuses on developing innovative medicines in areas such as diabetes, oncology, and neurodegeneration. Their business model emphasizes research and development, strategic partnerships, and a strong commitment to improving patient outcomes through advanced therapeutics.
More about Eli Lilly And Company's Market Share
|
Sources: Gelesis Holdings Inc and all companies mentioned above in this report
|
